Artificial intelligence (AI) is revolutionizing eye exams, particularly in the detection of diabetic retinopathy, the leading cause of blindness among working-age adults. An AI algorithm implemented in clinics is able to perform eye exams using retinal images, providing quick diagnoses without the need for a doctor to be present. This saves time, reduces costs, and increases accessibility for patients. Several companies have received FDA approval for their AI eye exams, and the Centers for Medicare & Medicaid Services (CMS) has provided a reimbursement code to facilitate adoption. The technology is evolving, with ongoing studies exploring new applications and potential advancements in screening for other eye diseases.